Aftificial Inteligence in Assisted Reproductive Techniques to Assess Oocyte Quality and Embryo Ploidy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-49
SponsorCharles University, Czech Republic

About this trial

The assisted reproduction success rate is affected by several factors including the age of the women, oocyte quality and maturation state, as well as sperm quality. Imaging of the meiotic spindle may be crucial for determining the oocyte maturation. Artificial intelligence (AI) will be applied to establish the complex oocyte quality, embryo ploidy and pregnancy success probability from the sequence of data, starting with the recording of the meiotic spindle in polarized light, through paternal factors up to the time lapse recording of early embryo development. This strategy should reduce the cost of fertility treatment thanks to increased efficiency in choosing the most promising candidates and reducing the need for costly laboratory analyses.

Eligibility criteria

Qualifiers

Intracytoplasmatic Sperm Injection

Preimplantation genetic testing

Time lapse embryo record

Singned informed consent

Disqualifiers

Gynecological diseases

Genetical diseases of parents

Trial design

Treatments tested in this trial

  • arteficial inteligence evaluation of oocyte and embryo development

Treatment groups

No treatment groups listed

Sponsors and collaborators

Charles University, Czech Republic

Lead sponsor

Czech Academy of Sciences

Collaborator

Czech Technical University in Prague

Collaborator

General University Hospital, Prague

Collaborator